- Home
- INZY vs PRE Comparison
INZY vs PRE Comparison
Compare INZY & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- PRE
- Stock Information
- Founded
- INZY 2015
- PRE 2014
- Country
- INZY United States
- PRE Hong Kong
- Employees
- INZY N/A
- PRE N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- INZY Health Care
- PRE Industrials
- Exchange
- INZY Nasdaq
- PRE Nasdaq
- Market Cap
- INZY 64.9M
- PRE 52.5M
- IPO Year
- INZY 2020
- PRE N/A
- Fundamental
- Price
- INZY $1.15
- PRE $5.39
- Analyst Decision
- INZY Strong Buy
- PRE Buy
- Analyst Count
- INZY 9
- PRE 1
- Target Price
- INZY $17.22
- PRE $9.00
- AVG Volume (30 Days)
- INZY 1.1M
- PRE 11.7K
- Earning Date
- INZY 05-20-2025
- PRE 06-17-2025
- Dividend Yield
- INZY N/A
- PRE N/A
- EPS Growth
- INZY N/A
- PRE N/A
- EPS
- INZY N/A
- PRE N/A
- Revenue
- INZY N/A
- PRE $30,621,000.00
- Revenue This Year
- INZY N/A
- PRE $148.70
- Revenue Next Year
- INZY N/A
- PRE $82.89
- P/E Ratio
- INZY N/A
- PRE N/A
- Revenue Growth
- INZY N/A
- PRE 40.83
- 52 Week Low
- INZY $0.72
- PRE $3.10
- 52 Week High
- INZY $6.24
- PRE $6.99
- Technical
- Relative Strength Index (RSI)
- INZY 50.96
- PRE 69.92
- Support Level
- INZY $1.18
- PRE $5.07
- Resistance Level
- INZY $1.63
- PRE $5.40
- Average True Range (ATR)
- INZY 0.20
- PRE 0.35
- MACD
- INZY 0.02
- PRE 0.05
- Stochastic Oscillator
- INZY 23.66
- PRE 89.16
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.